(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ACTELION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

ACTELION

ST13

US500000079081187

Class

5, 44

Filing

79081187

Registration

3983464

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

03/15/2025

Classification

Registered

Trademark type

Combined

Nice classes

5, 44

Filing date

03/23/2010

Registration date

06/28/2011

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/14/2022

Last transaction

03/15/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

CH

Examiner

MCCAULEY, BRENDAN

Law office

M50

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of an arc, visually the initiating end is wider than the terminating end. The underside of the arc displays a series of circles from the left side of the arc following the curve to the middle of the arc. The term "ACTELION" appears near the arc.

Holders and representatives

Holders

Actelion Pharmaceuticals Ltd.

Representatives

Cheryl Foytlin Johnson & Johnson

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of glycolipid storage diseases; Pharmaceutical preparations for the treatment of cerebrovascular diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system and of the peripheral neurological system; Pharmaceutical preparations for the treatment of insomnia and other sleep related diseases; hypnotics and sedatives; Pharmaceutical preparations for the treatment of obesity and eating disorders; Pharmaceutical preparations for the treatment of addiction; Pharmaceutical preparations for the treatment of cognitive disorders; Pharmaceutical preparations for the treatment of gastrointestinal disorders; Pharmaceutical preparations for the treatment of auto-immune disorders; Pharmaceutical preparations for the treatment of digital ulcers; anxiolytics; anti-allergics; anti-infectives

Class 44

Medical servicesproviding medical information regarding pharmaceutical products and healthcare to healthcare professionals and patients

Publications

History of USPTO decisions and trademark events.

52 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/14/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/05/2023

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

10/30/2022

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/30/2022

INPC

INVALIDATION PROCESSED

09/30/2022

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

09/14/2022

C71T

CANCELLED SECTION 71

01/14/2022

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

06/28/2020

RNWL

INTERNATIONAL REGISTRATION RENEWED

04/30/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/15/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/06/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/06/2018

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/07/2017

71AG

REGISTERED-SEC.71 ACCEPTED

06/07/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/06/2017

ES71

TEAS SECTION 71 RECEIVED

02/09/2017

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/28/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/30/2013

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/21/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/22/2011

FIMP

FINAL DISPOSITION PROCESSED

11/22/2011

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/28/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

06/28/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/12/2011

PUBO

PUBLISHED FOR OPPOSITION

04/12/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/24/2011

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/24/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/08/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/01/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

03/01/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/01/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

03/01/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/01/2011

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

02/28/2011

PBTQ

WITHDRAWN FROM PUB OTQR REQUEST

02/05/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/25/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/18/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/14/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/14/2011

ALIE

ASSIGNED TO LIE

01/14/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/28/2010

RFNT

REFUSAL PROCESSED BY IB

07/30/2010

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/28/2010

RFRR

REFUSAL PROCESSED BY MPU

06/28/2010

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/26/2010

CNRT

NON-FINAL ACTION WRITTEN

06/25/2010

DOCK

ASSIGNED TO EXAMINER

06/23/2010

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/19/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/19/2010

MAFR

APPLICATION FILING RECEIPT MAILED

05/04/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/30/2010

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/29/2010

Continuous trademark protection

Get notified about every new filing that threatens ACTELION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.